ASX:DRUG Holdings Information

ASX:DRUG is an equity ETF with a total of 80 individual holdings. The top holdings are Johnson & Johnson stock at 8.92%, Eli Lilly and Company at 7.76%, AbbVie at 6.80%, ROCHE HOLDING AG at 5.10%, and UnitedHealth Group at 4.97%.

Total Holdings

Top 10 Percentage

51.83%

Asset Class

Equity

ETF Category

Health Care

Assets

169.43M

PE Ratio

23.48

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	JNJ	Johnson & Johnson	8.92%	40,369
2	LLY	Eli Lilly and Company	7.76%	8,232
3	ABBV	AbbVie Inc.	6.80%	31,507
4	ROP.SE	ROCHE HOLDING AG	5.10%	14,237
5	UNH	UnitedHealth Group Incorporated	4.97%	16,195
6	MRK	Merck & Co., Inc.	4.61%	38,310
7	TMO	Thermo Fisher Scientific Inc.	3.95%	7,335
8	NOVN.SE	NOVARTIS AG	3.47%	30,162
9	LON: AZN	AstraZeneca PLC	3.32%	24,447
10	AMGN	Amgen Inc.	2.95%	9,507
11	ABT	Abbott Laboratories	2.72%	32,532
12	GILD	Gilead Sciences, Inc.	2.70%	21,871
13	PFE	Pfizer Inc.	2.41%	106,449
14	NOVOB.DC	NOVO NORDISK A/S	2.40%	68,355
15	DHR	Danaher Corporation	2.30%	13,219
16	BMY	Bristol-Myers Squibb Company	2.09%	40,741
17	ISRG	Intuitive Surgical, Inc.	2.07%	6,615
18	MDT	Medtronic plc	1.82%	23,979
19	LON: GSK	GSK plc	1.66%	80,036
20	SYK	Stryker Corporation	1.66%	7,241
21	VRTX	Vertex Pharmaceuticals Incorporated	1.57%	3,717
22	SAN.FP	SANOFI	1.56%	22,161
23	ELV	Elevance Health, Inc.	1.37%	4,056
24	REGN	Regeneron Pharmaceuticals, Inc.	1.24%	1,924
25	HCA	HCA Healthcare, Inc.	1.14%	3,249

Showing 25 of 80 holdings

Subscribe to see the full list

Activate Now

As of Sep 17, 2026